Lumicell
Lumicell Appoints Marnie Curbow as Chief Executive Officer
Lumicell announced a leadership change on October 19, 2026. Lumicell promoted Chief Commercial Officer Marnie Curbow to Chief Executive Officer, effective immediately, to lead the company as it enters its next phase of commercial growth.
What changed
Marnie Curbow was named Chief Executive Officer. Marnie Curbow was promoted to Chief Executive Officer from her role as Chief Commercial Officer, and the announcement did not name a predecessor.
- Leader: Marnie Curbow
- Role: Chief Executive Officer
- Effective: Effective immediately
- Announcement date: October 19, 2026
Leadership background
Curbow joined Lumicell in October 2025 as Vice President of Sales and was promoted to Chief Commercial Officer, taking on sales, marketing, reimbursement, and clinical applications. Before Lumicell, she was GM and VP Sales Diagnostics for the Americas at Rhinomed, where she launched a novel diagnostic and secured a SPARK accelerator award from BARDA. The company said she has nearly two decades of experience spanning breast oncology, surgery, diagnostics, and therapeutics.
The mandate
Lumicell said Curbow will lead the company as it enters its next phase of commercial growth, and that the company will continue to focus on advancing adoption of pegulicianine fluorescence-guided surgery (pFGS), strengthening its commercial and clinical partnerships, expanding its investor base, and pursuing opportunities to expand the application of its technology across additional solid tumor indications.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: Lumicell leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


